Back
Matthews Emerging Markets Equity Active ETF Vs. Novo Nordisk A/S Industry Stock Comparison
Sell
31
MEM
Matthews Emerging Markets Equity Active ETF
Last Price:
$36.53
Seasonality Move:
-1.17%
Sell
20
NVO
Novo Nordisk A/S
Last Price:
$48.11
Seasonality Move:
4.04%
Sell
31
Matthews Emerging Markets Equity Active ETF (MEM)
is a Sell
Is Matthews Emerging Markets Equity Active ETF a Buy, Sell or Hold?
-
The current Matthews Emerging Markets Equity Active ETF [MEM] share price is $34.83. The Score for MEM is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
MEM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
Novo Nordisk A/S (NVO)
is a Sell
Is Novo Nordisk A/S a Buy, Sell or Hold?
-
The current Novo Nordisk A/S [NVO] share price is $47.61. The Score for NVO is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
MEM Stock Price Chart
What is Matthews Emerging Markets Equity Active ETF's stock price today?
-
The Matthews Emerging Markets Equity Active ETF share price today is $34.83Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MEM is experiencing slight selling pressure.
NVO Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $47.61Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing selling pressure, which indicates risk of future bearish movement.
MEM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.29 | Sell |
| Relative Strength Index (14 RSI): | 32.8 | Sell |
| Chaikin Money Flow: | -2277 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.64 - 36.9) | Sell |
| Bollinger Bands (100): | (34.06 - 37.1) | Sell |
NVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.31 | Sell |
| Relative Strength Index (14 RSI): | 44.82 | Sell |
| Chaikin Money Flow: | -6318846 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.96 - 49.4) | Sell |
| Bollinger Bands (100): | (48.16 - 56.94) | Sell |
MEM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.09 | Sell |
| 20-day SMA: | 36.22 | Sell |
| 50-day SMA: | 36.56 | Sell |
| 200-day SMA: | 33.15 | Buy |
| 8-day EMA: | 35.75 | Sell |
| 20-day EMA: | 36.19 | Sell |
| 50-day EMA: | 36.22 | Sell |
| 200-day EMA: | 34.02 | Buy |
NVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.82 | Sell |
| 20-day SMA: | 48.1 | Sell |
| 50-day SMA: | 50.21 | Sell |
| 200-day SMA: | 61.08 | Sell |
| 8-day EMA: | 48.51 | Sell |
| 20-day EMA: | 48.56 | Sell |
| 50-day EMA: | 50.31 | Sell |
| 200-day EMA: | 63.25 | Sell |
Matthews Emerging Markets Equity Active ETF Earnings Growth & MEM Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novo Nordisk A/S Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.54 per share, and a decrease next year of $0.15 per share.
Matthews Emerging Markets Equity Active ETF Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk A/S Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||